While reporting its results for the first quarter on Thursday, medical devices company CooperCompanies (COO), updated its fiscal year 2025 financial guidance.
For the fiscal year 2025, adjusted earnings per share is expected to be $3.94 to $4.02, raised from previous guidance of $3.92 to $4.02.
The company continues to expect fiscal 2025 total revenue of $4,080 million to $4,158 million, and organic growth of 6% to 8%.
CVI revenue is expected to be $2,733 million to $2,786 million and CSI revenue of $1,347 million to $1,372 million.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.